Impact of Morning Symptoms in Clinical Control of Chronic Obstructive Pulmonary Disease (COPD)
IMPAEPOC
1 other identifier
observational
1,268
1 country
52
Brief Summary
Observational study to know the Impact of morning symptoms in clinical control of COPD patients. 1200 patients will be included by General practitioners (GPs) and pneumologists. Objective: establish if there are differences in the impact of COPD on daily activities and morning symptoms measured through questionnaires of daily life activity (Capacity of Daily Living during the Morning (CDLM), Global Chest Symptoms Questionnaire (GCSQ))
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2010
52 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
December 21, 2010
CompletedFirst Posted
Study publicly available on registry
December 24, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedAugust 9, 2011
August 1, 2011
December 21, 2010
August 8, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Determine if there are differences in the impact of COPD on patients according to the characteristics of the disease. To measure the impact of specific self-administered questionnaires used in COPD: CDLMQ, GCSQ and CCQ
Capacity of Daily Living during the Morning Qustionnaire (CDLMQ), Global Chest Symptoms Questionnaire (GCSQ)and COPD Control Questionnaire (CCQ)
Retrospective, (previous 24 months)
Secondary Outcomes (1)
Assess comorbidities as a risk factor for frequent exacerbations
Retrospective, (previous 24 months)
Eligibility Criteria
General Practitioners and pneumologist
You may qualify if:
- Patient has signed informed consent form
- Patients of both sexes,\> 40 years.
- Patients diagnosed with COPD according to global consensus on the definition, classification and management of the disease (GOLD) criteria:
- post-bronchodilator forced expiratory volume in 1 s (FEV1) / forced vital capacity (FVC) \<70%
- post-bronchodilator FEV1 \<80% (stage II, III and IV)
You may not qualify if:
- Participating in an epidemiological study or clinical trial
- Patient with other respiratory disease than COPD (eg bronchial asthma, cystic fibrosis, severe bronchiectasis, restrictive lung disease, cancer, etc.).
- Patients with mild COPD: FEV1\> 80%
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (52)
Research Site
Vitoria-Gasteiz, Alava, Spain
Research Site
Elda, Alicante, Spain
Research Site
Petrel, Alicante, Spain
Research Site
Almería, Almeria, Spain
Research Site
Ávila, Avila, Spain
Research Site
Badajoz, Badajoz, Spain
Research Site
Inca, Balearic Islands, Spain
Research Site
Son Ferriol, Balearic Islands, Spain
Research Site
Barcelona, Barcelona, Spain
Research Site
El Hospitalet de Llobregat, Barcelona, Spain
Research Site
Puerto Real, CAdiz, Spain
Research Site
Castellon, Castellon, Spain
Research Site
Torreblanca, Castellon, Spain
Research Site
Vinaròs, Castellon, Spain
Research Site
Lucena, Cordoba, Spain
Research Site
Pea'arroya-pueblonuevo, Cordoba, Spain
Research Site
A Picota (mazaricos), Coruna, Spain
Research Site
Carballo (carballo), Coruna, Spain
Research Site
Ferrol, Coruna, Spain
Research Site
Santiago de Compostela, Coruna, Spain
Research Site
Guadalajara, Guadalajara, Spain
Research Site
Donostia / San Sebastian, Guipuzcoa, Spain
Research Site
Placencia de Las Armas-soraluz, Guipuzcoa, Spain
Research Site
Espelúy, Jaen, Spain
Research Site
Mures, Jaen, Spain
Research Site
Nájera, La Rioja, Spain
Research Site
Arguineguín, Las Palmas, Spain
Research Site
Abadin (casco Urbano), Lugo, Spain
Research Site
Baralla (casco Urbano), Lugo, Spain
Research Site
Lugo, Lugo, Spain
Research Site
Viveiro (casco Urbano), Lugo, Spain
Research Site
Alcalá de Henares, Madrid, Spain
Research Site
Alcorcón, Madrid, Spain
Research Site
Madrid, Madrid, Spain
Research Site
San Sebastián de los Reyes, Madrid, Spain
Research Site
Cieza, Murcia, Spain
Research Site
Murcia, Murcia, Spain
Research Site
Pamplona, Navarre, Spain
Research Site
Leiro (capital), Ourense, Spain
Research Site
Vigo, Pontevedra, Spain
Research Site
Arriondas, Principality of Asturias, Spain
Research Site
Cangas de Narcea, Principality of Asturias, Spain
Research Site
Jarrio, Principality of Asturias, Spain
Research Site
Oviedo, Principality of Asturias, Spain
Research Site
Dos Hermanas, Sevilla, Spain
Research Site
Seville, Sevilla, Spain
Research Site
Villanueva del Ariscal, Sevilla, Spain
Research Site
Benaguasil, Valencia, Spain
Research Site
Burjassot, Valencia, Spain
Research Site
La Pobla de Vallbona, Valencia, Spain
Research Site
Valencia, Valencia, Spain
Research Site
Zaragoza, Zaragoza, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
December 21, 2010
First Posted
December 24, 2010
Study Start
January 1, 2010
Study Completion
July 1, 2011
Last Updated
August 9, 2011
Record last verified: 2011-08